A Study of RPL554 Drug Administered by Metered Dose Inhaler to Treat Chronic Obstructive Pulmonary Disease
Condition: COPD Interventions: Drug: Ensifentrine 100mcg; Drug: Ensifentrine 300mcg; Drug: Ensifentrine 1000mcg; Drug: Ensifentrine 3000mcg; Drug: Ensifentrine 6000mcg; Drug: Placebos Sponsors: Verona Pharma plc; Iqvia Pty Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials